MedTrace Logo

Fixed Dose Triple Therapy in Severe Chronic Obstructive Pulmonary Disease in a Real World Setting

NCT03627858 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 149

Last updated 2021-11-29

No results posted yet for this study

Summary

The rationale for this non-interventional study in confirmed moderate to severe chronic obstructive pulmonary disease patients aged 40 years and above, is to assess real-life effectiveness and safety of Trimbow® in clinical practice, and to bridge the gap with the existing clinical data.

Conditions

Interventions

DRUG

beclomethasone / formoterol / glycopyrronium

As this is a non-interventional study, all treatment decisions will be made at the discretion of the treating physician prior to enrolment in the study and during the entire period of the study. Treatment will be prescribed according to the product label in the summary of product characteristics.

Sponsors & Collaborators

  • Chiesi SA/NV

    lead OTHER

Principal Investigators

  • Guy Brusselle, MD-PhD · University Ghent

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2020-08-03
Completion
2020-08-03

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03627858 on ClinicalTrials.gov